Post by PPD

📣 New registry launch: Advancing real-world evidence in chronic hand eczema (CHE) We’re thrilled to introduce the PPD™ CorEvitas™ CHE Registry — designed to generate robust, prospective real-world data to better understand the patient journey and treatment landscape in chronic hand eczema. Through proprietary longitudinal data collection, including both clinician- and patient-reported outcomes, the registry enables deeper insights into disease progression, treatment patterns, effectiveness and long-term safety in routine clinical practice. For sponsors and drug developers, this creates a powerful opportunity to address critical research questions, support evidence generation across the product life cycle and ultimately improve outcomes for patients living with CHE. Together, we can help shape a more informed, patient-centered future for dermatologic care. 📰 Learn more: http://spr.ly/6048BDzlga